ATC Group: R07AX01 Nitric oxide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R07AX01 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R07 Other respiratory system products
3 R07A Other respiratory system products
4 R07AX Other respiratory system products
5 R07AX01 Nitric oxide

Active ingredients in R07AX01

Active Ingredient Description
Nitric oxide (NO)

Nitric oxide is a compound produced by many cells of the body. It relaxes vascular smooth muscle by binding to the haeme moiety of cytosolic guanylate cyclase. When inhaled, nitric oxide produces selective pulmonary vasodilation.

Related product monographs

Title Information Source Document Type  
INOMAX Inhalation gas European Medicines Agency (EU) MPI, EU: SmPC
KINOX Inhalation gas Health Products and Food Branch (CA) MPI, CA: SPM
NEOPHYR Medicinal gas, compressed Health Products Regulatory Authority (IE) MPI, EU: SmPC
NOXIVENT 101 Inhalation gas FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Poland (PL)

Romania (RO)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.